Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma

Oncogene

Volumn 27, Issue 5, 2008, Pages 663-674

  Scavelli, C ^a   Nico, B ^a   Cirulli, T ^a   Ria, R ^a   Di Pietro, G ^a   Mangieri, D ^a   Bacigalupo, A ^b   Mangialardi, G ^a   Coluccia, A M L ^a   Caravita, T ^c   Molica, S ^d   Ribatti, D ^a   Dammacco, F ^a   Vacca, A ^a,e  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c S EUGENIO HOSPITAL   (Italy)

^d PUGLIESE CIACCIO HOSPITAL   (Italy)

^e POLICLINICO   (Italy)

Author keywords

Basic fibroblast growth factor; Macrophages; Multiple myeloma; Vascular endothelial growth factor; Vasculogenesis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ADULT; AGED; ANEMIA; ARTICLE; BIOASSAY; BONE MARROW; BONE MARROW BIOPSY; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MACROPHAGE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BONE MARROW CELLS; CASE-CONTROL STUDIES; CELL CULTURE TECHNIQUES; DISEASE PROGRESSION; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; PARAPROTEINEMIAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38549141574     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210691     Document Type: Article

References (45)

1. Anghelina M, Krishnan P, Moldovan L, Moldovan NI. (2004). Monocytes and macrophages form branched cell columns in matrigel: implications for their role in neovascularization. Stem Cells Dev 13: 665-676.
2. Anghelina M, Krishnan P, Moldovan L, Moldovan NI. (2006a). Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Am J Pathol 168: 529-541.
3. Anghelina M, Moldovan L, Zabuawala T, Ostrowski MC, Moldovan NI. (2006b). A subpopulation of peritoneal macrophages form capillary like lumens and branching patterns in vitro. J Cell Mol Med 10: 708-715.
4. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor Flt-1. Blood 87: 3336-3343.
5. Baroni CD, Vitolo D, Remoti D, Biondi A, Pezzella F, Ruco LP et al. (1987). Immunohistochemical heterogeneity of macrophage subpopulations in human lymphoid tissues. Histopathology 11: 1029-1042.
6. Bellamy WT, Richter L, Frutiger Y, Grogan TM. (1999). Expression of vascular endothelial growth factor and its receptors in hematological malignancies. Blood 59: 728-733.
7. Bender AT, Ostenson CL, Giordano D, Beavo JA. (2004). Differentiation of human monocytes in vitro with granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor produces distinct changes in cGMP phosphodiesterase expression. Cell Signal 16: 365-374.
8. Bender CM, Pao MM, Jones PA. (1998). Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 58: 95-101.
9. Cavallaro U, Liebner S, Dejana E. (2006). Endothelial cadherins and tumor angiogenesis. Exp Cell Res 312: 659-667.
10. Conejo-Garcia JR, Buckanovich RJ, Benencia F, Courreges MC, Rubin SC, Carroll RG et al. (2005). Vascular leukocytes contribute to tumor vascularization. Blood 105: 679-681.
11. Di Raimondo F, Azzaro MP, Palombo G, Bagnato S, Giustolisi G, Floridia P et al. (2000). Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica 85: 800-805.
12. Dome B, Hendrix MJ, Paku S, Tovari J, Timar J. (2007). Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am J Pathol 170: 1-15.
13. Durie BG. (1986). Staging and kinetics of multiple myeloma. Semin Oncol 13: 300-309.
14. Fehrenbach H, Tews S, Fehrenbach A, Ochs M, Wittwer T, Wahlers T et al. (2005). Improved lung preservation relates to an increase in tubular myelin-associated surfactant protein A. Respir Res 6: 60-71.
15. Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, Zuzarte ML et al. (2000). Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65: 287-300.
16. Folkman J, Browder T, Palmblad J. (2001). Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost 86: 23-33.
17. Fong GH, Rossant J, Gertsenstein M, Breitman ML. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.
18. Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, Nozawa Y et al. (2003). Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 93: 980-989.
19. Gendron RL, Tsai FY, Paradis H, Arceci RJ. (1996). Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo. Dev Biol 177: 332-346.
20. Goto F, Goto K, Weindel K, Folkman J. (1993). Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69: 508-517.
21. Guidolin D, Vacca A, Nussdorfer GG, Ribatti D. (2004). A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro. Microvasc Res 67: 117-124.
22. Hart DN. (1997). Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90: 3245-3287.
23. International Myeloma Working Group (2003). Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121: 749-757.
24. Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, Bartel G et al. (2006). Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 12: 230-234.
25. Kumar S, Witzig TE, Timm M, Haug J, Wellik L, Kimlinger TK et al. (2004). Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression. Blood 104: 1159-1165.
26. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25: 402-408.
27. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J et al. (1999). Vascular tunnel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155: 739-752.
28. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA. (2007). Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 170: 1178-1191.
29. Moldovan NI. (2005). Functional adaptation: the key to plasticity of cardiovascular 'stem' cells? Stem Cells Dev 14: 111-121.
30. Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, Shapiro SD, Kolattukudy E. (2000). Contribution of moncytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res 87: 378-384.
31. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M et al. (2000). Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95: 952-958.
32. Pepper MS, Ferrara N, Orci L, Montesano R. (1992). Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189: 824-831.
33. Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR. (1999). Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma. Leukemia 13: 469-472.
34. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. (1996). Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA 93: 14833-14838.
35. Rehman J, Li J, Orschell CM, March KL. (2003). Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
36. Ribatti D, Nico B, Vacca A. (2006). Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25: 4257-4266.
37. Risau W, Sariola H, Zerwes HG, Sasse J, Ekblom P, Kemler R et al. (1988). Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102: 471-478.
38. Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J et al. (2001). Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigels under angiogenic conditions. Cardiovasc Res 49: 671-680.
39. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES et al. (1998). Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141: 1659-1673.
40. Shalaby F, Ho J, Stanford WL, Fischer KD, Schuh AC, Schwartz L et al. (1999). A requirement for Flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89: 981-990.
41. Vacca A, Ria R, Semeraro F, Merchionne F, Coluccia M, Boccarelli A et al. (2003). Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 102: 3340-3348.
42. Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R et al. (1999). Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 93: 3064-3073.
43. Vacca A, Scavelli C, Montefusco V, Di Pietro G, Neri A, Mattioli M et al. (2005). Thalidomide down-regulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma. J Clin Oncol 23: 5334-5346.
44. Zhang H, Vakil V, Braunstein M, Smith EL, Maroney J, Chen L et al. (2005). Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 105: 3286-3294.
45. Zhao Y, Glesne D, Huberman E. (2003). A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 100: 2426-2431.